INDOUS quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Indo Us Bio-Tech Ltd reported sales of ₹- Cr, operating profit of ₹- Cr (OPM -) and net profit of ₹- Cr for the quarter ended Mar 2022. Figures in ₹ crore, consolidated where available.
INDOUS quarterly results (₹ Cr)
Metric
Mar 2020
Sep 2020
Mar 2021
Sep 2021
Mar 2022
Sales
-
-
-
-
-
Expenses
-
-
-
-
-
Operating Profit
-
-
-
-
-
OPM
-
-
-
-
-
Other Income
-
-
-
-
-
Interest
-
-
-
-
-
Depreciation
-
-
-
-
-
Profit before tax
-
-
-
-
-
Tax
-
-
-
-
-
Net Profit
-
-
-
-
-
EPS in Rs
-
-
-
-
-
INDOUS profit & loss, annual (₹ Cr)
Metric
Mar 2020
Mar 2021
Mar 2022
Sales
39.76
39.39
49.39
Expenses
35.78
34.04
42.6
Operating Profit
3.98
5.35
6.79
OPM
10.01%
13.58%
13.75%
Other Income
-0.01
0.03
0.18
Interest
0.88
1.18
1.2
Depreciation
0.23
0.27
0.46
Profit before tax
2.86
3.93
5.31
Tax
11.54%
-24.68%
4.71%
Net Profit
2.53
4.9
5.06
EPS in Rs
1.74
3.38
2.77
Dividend Payout
0%
0%
0%
INDOUS balance sheet (₹ Cr)
Metric
Mar 2020
Mar 2021
Mar 2022
Equity Capital
6.07
6.07
9.17
Reserves
10.37
15.27
29.34
Borrowings
8.58
11.57
12.84
Other Liabilities
9.68
10.8
4.27
Total Liabilities
34.7
43.71
55.62
Fixed Assets
1.41
2.37
5.55
CWIP
1.28
1.99
2.32
Investments
0
0
0
Other Assets
32.01
39.35
47.75
Total Assets
34.7
43.71
55.62
INDOUS cash flows (₹ Cr)
Metric
Mar 2020
Mar 2021
Mar 2022
Cash from Operating Activity
-0.84
0.16
2.7
Cash from Investing Activity
-0.57
-1.78
-5.44
Cash from Financing Activity
1.53
1.55
2.65
Net Cash Flow
0.12
-0.07
-0.09
Free Cash Flow
-1.21
-1.78
-1.27
CFO/OP
-20%
6%
46%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit